The global probiotic infant formula market size is projected to increase from USD 526.2 million in 2024 to USD 1,281.2 million by 2034. By 2034, global probiotic infant formula sales are set to soar at 5.2% CAGR.
| Attributes | Key Insights |
|---|---|
| Probiotic Infant Formula Market Size (2024E) | USD 526.2 million |
| Market Value (2034F) | USD 1,281.2 million |
| Value-based CAGR (2024 to 2034) | 5.2% |
With the accelerating problems of gut health and digestive disorders among infants, consumption of probiotic infant formulas is rising rapidly. Rising population of working women is set to create new opportunities for leading companies in the market.
High living costs are compelling working women to support their families financially. Hence, they are relying on infant formula to provide a complete nutrition profile for their growing babies.
The infant formula market is further propelled by increasing awareness among today’s consumers about the growing need for extra nutrition. They are also gradually accepting new formulas other than breast milk. Parents are increasingly choosing formulas with fewer artificial ingredients and organic origins, fueling demand for probiotic infant formula in the market.
Top companies are focusing on meeting the parents' needs for convenience, ease of consumption, and taste acceptability by babies for high sales. Government initiatives and improved access to pediatric care have increased parents' awareness of infant nutritional needs and alternatives to breast milk & safe infant food items.
Marketing tactics such as performance marketing through social media bloggers and influencers have elevated awareness about probiotics-infused infant formulas and have helped widen the customer base. According to Future Market Insights (FMI), considering the upward trajectory of digestive disorders and the need for easy & convenient nutrition-dense infant food, the global market is poised for strong growth by 2034.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global market displayed steady sales growth from 2019 to 2023. Consumer interest in probiotics has surged due to scientific research on their efficacy and safety in infant health. Some infant formula companies are focusing on research activities to discover the effects of probiotic supplementation on allergy prevention, immune function, and digestive health in an infant.
The industry has grown significantly due to increased consumer awareness of gut health and the desire for natural, organic products. Key companies have introduced probiotic-infused formulas targeting specific health benefits using strains such as Bifidobacterium, Lactobacillus. Innovations in formulation and manufacturing technologies, such as microencapsulation, have improved the viability and stability of probiotic strains in infant formula.
By 2034, global probiotic infant formula sales are set to soar at 5.2% CAGR. This is attributed to growing awareness of the product’s health benefits and high disposable income of millennials to spend on indulgent commodities. Manufacturers’ vast investment results in diverse product formats and flavors, boosting sales in the market.
Growing population and birth rates contribute to its extensive consumer base worldwide. The market is further projected to inflate through retail channels such as hypermarkets and online e-commerce platforms, with brands strategically positioning themselves through competitive pricing.
Principal Consultant
The table below shows the predicted growth rates of the leading countries. The United States, India, and Australia are anticipated to record high CAGRs of 4.5%, 6.2%, and 7.1%, respectively, through 2034.
| Countries | CAGR (2024 to 2034) |
|---|---|
| United States | 4.5% |
| Germany | 3.4% |
| India | 6.2% |
| Australia | 7.1% |
The table below lists the countries with high demand for infant formula according to the analysis of the global industry.
| Countries | Value (2034) |
|---|---|
| United States | USD 260.1 million |
| Germany | USD 146.1 million |
| India | USD 79.4 million |
| Australia | USD 39.7 million |
The United States probiotic infant formula market is experiencing rapid growth due to numerous manufacturers' innovation and development efforts. Leading companies focus on developing high-quality, nutrition-profile products due to market competition and consumer demand for easy, convenient items.
High purchasing power fuels market growth, as consumers spend on indulgent products that save time and promote health. The United States is projected to surge at a CAGR of 4.5% by 2034.
Sales of Australia is set to reach USD 39.7 million, propelling at a CAGR of 7.1% by 2034. The market value is being significantly boosted by rising clean-label, natural, and organic formulations, and consumer awareness of the harmful effects of chemicals in food.
Customers are actively seeking transparency in their purchasing decisions, particularly regarding the source, provenance, and manufacturing process used. Companies that provide detailed product ingredient lists will likely gain more customer trust, fueling the market.
India's sales is increasing rapidly, owing to the country's growing population and birth rates. Increasing number of newborns in India fuels the infant formula market, particularly the probiotic variant, as parents increasingly invest in premium products for their infants' health.
India's market is propelling due to rising demand and regulatory bodies' safety and efficacy standards. India is set to reach USD 79.4 million by 2034.
Parents in Germany are increasingly aware of the importance of probiotics in infant gut health, leading to a surging demand for probiotic formula to support their babies' digestive and immune systems. Consumers increasingly favor natural and organic infant formulas, seeking products free from artificial additives and organic ingredients.
Probiotic formulas are sold in Germany through various retail channels, including supermarkets, pharmacies, online retailers, and specialty stores, with companies surging their reach. Germany is set to reach USD 146.1 million by 2034.
Manufacturers in Japan are investing in research and development to improve probiotic infant formulas through progressions in strains, microencapsulation techniques, and delivery systems to ensure probiotic viability. Japan's probiotic infant formula market is highly competitive, with established and new entrants vying for market share, characterized by product quality, brand reputation, marketing strategies, and distribution channels.
Leading companies and non-government organizations promote probiotic infant formulas through advertising campaigns, educational materials for healthcare professionals, and social media outreach to engage parents. By 2034, Japan is projected to grow at a significant CAGR.
The table section offers detailed insights into key global probiotic infant formula industry segments. The information will help companies maximize profits by investing in popular ingredients and using preferred sales channels.
| Segment | Market Value (2034) |
|---|---|
| Infant (Age) | USD 512.4 million |
| Bifidobacteria (Ingredient) | USD 358.7 million |
| Online Retail (Sales Channel) | USD 230.6 million |
Based on age, the infant segment is projected to reach USD 512.4 million in 2034. While breastfeeding is recommended, several women find it difficult due to low milk supply, work engagements, or health concerns.
Probiotic infant formula offers a reliable alternative, ensuring complete nutrition for the newborn. It also provides flexibility, allowing both parents to share their responsibilities. Moreover, pediatricians are embracing probiotics for infants born through C-section delivery or those exposed to antibiotics during labor.
Based on the sales channel, the online retail segment is set to reach USD 230.6 million by 2034. Online platforms provide convenience and accessibility for busy parents to shop at their convenience.
Parents can choose the best infant formulas from various brands, supported by detailed product descriptions and customer testimonials for informed decision-making. E-commerce channels often run discounts, promotions, or deals to attract customers as price-conscious parents appreciate cost savings.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Leading companies are investing more in research and development for taste enhancement, improvised texture, and improved health benefits to generate high sales. Enfamil, Envivo, Nestlé Health Science, Nestlé Good Start, Bellamy's Organic, HiPP, Custom Probiotics Inc., and SFI Health are the key companies in the market.
Due to growing consumer demand for probiotic infant formulas, leading manufacturers are strategizing to provide their products at competitive pricing to gain an edge over competitors. They are engaging in collaborations and partnerships to better position themselves in the market to inflate their geographical presence and visibility.
For instance
The market is set to reach USD 526.2 million in 2024.
Demand for probiotic infant formula is slated to rise at a 5.2% CAGR by 2034.
The market is set to reach USD 1,281.2 million in 2034.
Enfamil, Envivo, and Nestlé Health Science are the key players.
Bifidobacteria segment is estimated to hold a significant market share in 2024.
1. Executive Summary
1.1. Global Market Outlook
1.2. Segmental Share Analysis
1.3. Dynamics Snapshot
1.4. Wheel of Fortune
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition
3. Market Dynamics
3.1. Drivers
3.1.1. Supply Side Drivers
3.1.2. Demand Side drivers
3.1.3. Economic Side Drivers
3.2. Restraints
3.3. Opportunity
3.4. Market trends By Region
3.5. Forecast Factors - Relevance & Impact
3.6. Regulations and Policies
4. Global Market - Pricing Analysis
4.1. Price Point Assessment by Region
4.1.1. Manufacturer Level Pricing
4.1.2. Distributor Level Pricing
4.2. Price Point Assessment By Age
4.3. Price Forecast till 2034
5. Value Chain Analysis
5.1. Operating margins at each node of supply chain
5.2. List of Active Market Participants
6. Global Market Size in Value (US$ million) and Volume (MT) Analysis 2019 to 2023 and Forecast, 2024 to 2034
6.1. Historical Market Size in Value (US$ million) and Volume (MT) Analysis, 2019 to 2023
6.2. Current and Future Market Size in Value (US$ million) and Volume (MT) Analysis, 2024 to 2034
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Age
7.1. Introduction / Key Findings
7.2. Historical Market Size in Value (US$ million) and Volume (MT) Analysis By Age, 2019 to 2023
7.3. Current and Future Market Size in Value (US$ million) and Volume (MT) Analysis and Forecast By Age, 2024 to 2034
7.3.1. Premature
7.3.2. Infant
7.3.3. Toddler
7.4. Market Attractiveness Analysis By Age
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Ingredient
8.1. Introduction / Key Findings
8.2. Historical Market Size in Value (US$ million) and Volume (MT) Analysis By Ingredient, 2019 to 2023
8.3. Current and Future Market Size in Value (US$ million) and Volume (MT) Analysis and Forecast By Ingredient, 2024 to 2034
8.3.1. Lactobacilli
8.3.2. Bifidobacteria
8.3.3. Others
8.4. Market Attractiveness Analysis by Ingredient
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Sales Channel
9.1. Introduction / Key Findings
9.2. Historical Market Size in Value (US$ million) and Volume (MT) Analysis by Sales Channel, 2019 to 2023
9.3. Current and Future Market Size in Value (US$ million) and Volume (MT) Analysis and Forecast By Sales Channel, 2024 to 2034
9.3.1. Online
9.3.1.1. Company Website
9.3.1.2. E-commerce Websites
9.3.2. Offline
9.3.2.1. Hypermarkets/Supermarkets
9.3.2.2. Convenience Stores
9.3.2.3. Specialty Stores
9.3.2.4. Departmental Stores
9.3.2.5. Drugstores
9.4. Market Attractiveness Analysis By Sales Channel
10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region
10.1. Introduction
10.2. Historical Market Size in Value (US$ million) and Volume (MT) Analysis By Region, 2019 to 2023
10.3. Current Market Size in Value (US$ million) and Volume (MT) Analysis and Forecast By Region, 2024 to 2034
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia
10.3.6. Oceania
10.3.7. Middle East and Africa
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
11.1. Introduction
11.2. Historical Market Size (US$ million) and Volume(MT) Trend Analysis By Market Taxonomy, 2019 to 2023
11.3. Market Size (US$ million) and Volume(MT) Forecast By Market Taxonomy, 2024 to 2034
11.3.1. By Country
11.3.1.1. United States
11.3.1.2. Canada
11.3.2. By Age
11.3.3. By Ingredient
11.3.4. By Sales Channel
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Age
11.4.3. By Ingredient
11.4.4. By Sales Channel
11.5. Key takeaways
12. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
12.1. Introduction
12.2. Historical Market Size (US$ million) and Volume(MT) Trend Analysis By Market Taxonomy, 2019 to 2023
12.3. Market Size (US$ million) and Volume(MT) Forecast By Market Taxonomy, 2024 to 2034
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Argentina
12.3.1.4. Rest of Latin America
12.3.2. By Age
12.3.3. By Ingredient
12.3.4. By Sales Channel
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Age
12.4.3. By Ingredient
12.4.4. By Sales Channel
12.5. Key takeaways
13. Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034
13.1. Introduction
13.2. Historical Market Size (US$ million) and Volume(MT) Trend Analysis By Market Taxonomy, 2019 to 2023
13.3. Market Size (US$ million) and Volume(MT) Forecast By Market Taxonomy, 2024 to 2034
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. United Kingdom
13.3.1.3. France
13.3.1.4. Italy
13.3.1.5. Spain
13.3.1.6. BENELUX
13.3.1.7. Nordic
13.3.1.8. Russia
13.3.1.9. Poland
13.3.1.10. Rest of Europe
13.3.2. By Age
13.3.3. By Ingredient
13.3.4. By Sales Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Age
13.4.3. By Ingredient
13.4.4. By Sales Channel
13.5. Key takeaways
14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034
14.1. Introduction
14.2. Historical Market Size (US$ million) and Volume(MT) Trend Analysis By Market Taxonomy, 2019 to 2023
14.3. Market Size (US$ million) and Volume(MT) Forecast By Market Taxonomy, 2024 to 2034
14.3.1. By Country
14.3.1.1. China
14.3.1.2. Japan
14.3.1.3. South Korea
14.3.2. By Age
14.3.3. By Ingredient
14.3.4. By Sales Channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Age
14.4.3. By Ingredient
14.4.4. By Sales Channel
14.5. Key takeaways
15. South Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034
15.1. Introduction
15.2. Historical Market Size (US$ million) and Volume(MT) Trend Analysis By Market Taxonomy, 2019 to 2023
15.3. Market Size (US$ million) and Volume(MT) Forecast By Market Taxonomy, 2024 to 2034
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Malaysia
15.3.1.4. Indonesia
15.3.1.5. Vietnam
15.3.1.6. Philippines
15.3.1.7. Singapore
15.3.1.8. Rest of South Asia
15.3.2. By Age
15.3.3. By Ingredient
15.3.4. By Sales Channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Age
15.4.3. By Ingredient
15.4.4. By Sales Channel
15.5. Key takeaways
16. Oceania Market Analysis 2019 to 2023 and Forecast 2024 to 2034
16.1. Introduction
16.2. Historical Market Size (US$ million) and Volume(MT) Trend Analysis By Market Taxonomy, 2019 to 2023
16.3. Market Size (US$ million) and Volume(MT) Forecast By Market Taxonomy, 2024 to 2034
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Age
16.3.3. By Ingredient
16.3.4. By Sales Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Age
16.4.3. By Ingredient
16.4.4. By Sales Channel
16.5. Key takeaways
17. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034
17.1. Introduction
17.2. Historical Market Size (US$ million) and Volume(MT) Trend Analysis By Market Taxonomy, 2019 to 2023
17.3. Market Size (US$ million) and Volume(MT) Forecast By Market Taxonomy, 2024 to 2034
17.3.1. By Country
17.3.1.1. GCC Countries
17.3.1.2. Turkiye
17.3.1.3. Egypt
17.3.1.4. South Africa
17.3.1.5. Rest of Middle East and Africa
17.3.2. By Age
17.3.3. By Ingredient
17.3.4. By Sales Channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Age
17.4.3. By Ingredient
17.4.4. By Sales Channel
17.5. Key takeaways
18. Country-level Market Analysis, 2024
18.1. United States Market Analysis
18.1.1. By Age
18.1.2. By Ingredient
18.1.3. By Sales Channel
18.2. Canada Market Analysis
18.2.1. By Age
18.2.2. By Ingredient
18.2.3. By Sales Channel
18.3. Brazil Market Analysis
18.3.1. By Age
18.3.2. By Ingredient
18.3.3. By Sales Channel
18.4. Mexico Market Analysis
18.4.1. By Age
18.4.2. By Ingredient
18.4.3. By Sales Channel
18.5. Argentina Market Analysis
18.5.1. By Age
18.5.2. By Ingredient
18.5.3. By Sales Channel
18.6. Germany Market Analysis
18.6.1. By Age
18.6.2. By Ingredient
18.6.3. By Sales Channel
18.7. United Kingdom Market Analysis
18.7.1. By Age
18.7.2. By Ingredient
18.7.3. By Sales Channel
18.8. France Market Analysis
18.8.1. By Age
18.8.2. By Ingredient
18.8.3. By Sales Channel
18.9. Italy Market Analysis
18.9.1. By Age
18.9.2. By Ingredient
18.9.3. By Sales Channel
18.10. Spain Market Analysis
18.10.1. By Age
18.10.2. By Ingredient
18.10.3. By Sales Channel
18.11. BENELUX Market Analysis
18.11.1. By Age
18.11.2. By Ingredient
18.11.3. By Sales Channel
18.12. Nordic Market Analysis
18.12.1. By Age
18.12.2. By Ingredient
18.12.3. By Sales Channel
18.13. Russia Region Market Analysis
18.13.1. By Age
18.13.2. By Ingredient
18.13.3. By Sales Channel
18.14. Poland Market Analysis
18.14.1. By Age
18.14.2. By Ingredient
18.14.3. By Sales Channel
18.15. China Market Analysis
18.15.1. By Age
18.15.2. By Ingredient
18.15.3. By Sales Channel
18.16. Japan Market Analysis
18.16.1. By Age
18.16.2. By Ingredient
18.16.3. By Sales Channel
18.17. South Korea Market Analysis
18.17.1. By Age
18.17.2. By Ingredient
18.17.3. By Sales Channel
18.18. India Market Analysis
18.18.1. By Age
18.18.2. By Ingredient
18.18.3. By Sales Channel
18.19. Thailand Market Analysis
18.19.1. By Age
18.19.2. By Ingredient
18.19.3. By Sales Channel
18.20. Malaysia Market Analysis
18.20.1. By Age
18.20.2. By Ingredient
18.20.3. By Sales Channel
18.21. Indonesia Market Analysis
18.21.1. By Age
18.21.2. By Ingredient
18.21.3. By Sales Channel
18.22. Vietnam Market Analysis
18.22.1. By Age
18.22.2. By Ingredient
18.22.3. By Sales Channel
18.23. Philippines Market Analysis
18.23.1. By Age
18.23.2. By Ingredient
18.23.3. By Sales Channel
18.24. Singapore Market Analysis
18.24.1. By Age
18.24.2. By Ingredient
18.24.3. By Sales Channel
18.25. Australia Market Analysis
18.25.1. By Age
18.25.2. By Ingredient
18.25.3. By Sales Channel
18.26. New Zealand Market Analysis
18.26.1. By Age
18.26.2. By Ingredient
18.26.3. By Sales Channel
18.27. GCC Countries Market Analysis
18.27.1. By Age
18.27.2. By Ingredient
18.27.3. By Sales Channel
18.28. Turkiye Market Analysis
18.28.1. By Age
18.28.2. By Ingredient
18.28.3. By Sales Channel
18.29. Egypt Market Analysis
18.29.1. By Age
18.29.2. By Ingredient
18.29.3. By Sales Channel
18.30. South Africa Market Analysis
18.30.1. By Age
18.30.2. By Ingredient
18.30.3. By Sales Channel
19. Market Structure Analysis
19.1. Global Market Competition - a Dashboard View
19.2. Industry Structure Analysis
19.2.1. % tier 1 market players
19.2.2. % tier 2 market players
19.2.3. % tier 3 market players
19.3. Global Market Company Share Analysis
19.3.1. For Tier 1 Market Players, 2023
19.3.2. Company Market Share Analysis of Top 5 Players, By Region
19.4. Key Participants Market Presence (Intensity Mapping) by Region
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Enfamil
20.3.1.1. Product Portfolio
20.3.1.2. Product Claim
20.3.1.3. Revenue by Market Segments (Product/Channel/Region)
20.3.1.4. Sales Footprint
20.3.1.5. Strategy Overview
20.3.1.5.1. Marketing Strategy
20.3.1.5.2. Product Strategy
20.3.1.5.3. Channel Strategy
20.3.1.6. SWOT Analysis
20.3.2. Envivo
20.3.3. Nestlé Health Science
20.3.4. Nestlé Good Start
20.3.5. Bellamy's Organic
20.3.6. HiPP
20.3.7. Custom Probiotics Inc.
20.3.8. SFI Health
20.3.9. Similac
20.3.10. Nutricia Neocate
20.3.11. New Beginnings Nutritionals
20.3.12. Others (on additional request)
21. Assumptions and Acronyms
22. Research Methodology
Explore Food and Beverage Insights
View Reports
Probiotic Infant Formula Market
